Minimize

Welcome!

Posts Tagged: theralase technologies
Now the third patient has been treated by Theralase! This completes the full patients to be tested for the Phase Ib NMIBC. now we...
Thu 20 Apr, 2017
2 comments
Below is the news on that the second patient has been treated for bladder cancer in the Theralase Phase 1b clinical study. Roger Dumoulin-White,...
Tue 18 Apr, 2017
6 comments
After a couple news releases this week we have Roger White, CEO and President of Theralase to provide an update. The Company has treated...
Thu 6 Apr, 2017
4 comments
Here is the news a lot of people (including us) were waiting for. Theralase has enrolled and treated its first patent just last week...
Tue 4 Apr, 2017
16 comments
This week’s show is shorter than the past couple week as I am currently in Japan visiting with a couple companies and taking some...
Sat 11 Feb, 2017
271 comments
The President and CEO of Theralase joins us to discuss the outlook for 2017 in terms of the cancer and therapeutic divisions. The Company...
Tue 17 Jan, 2017
4 comments
Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT: TSXV) (TLTFF: OTC), a leading biotech company focused on the commercialization of medical devices to eliminate...
Wed 14 Dec, 2016
2 comments
In the first hour of this week’s show we focus on gold, uranium and get a comment on Theralase. It was a significant week...
Sat 26 Nov, 2016
110 comments
More on the bladder cancer research currently on-going by Theralase Technologies with involvement by Princess Margaret Cancer...
Mon 21 Nov, 2016
3 comments
More theralase technologies

Part One of our discussion with Dr. Michael Jewett, who is the Chairman of the Photodynamic Therapy Medical and Scientific Advisory Board of Theralase

Blader Cancer research is on the way with Theralase Technologies and Dr. Michael Jewett MD explains the status of this research which is continuing with…

Mon 21 Nov, 2016
0 comment

Theralase Increases GBM Brain Cancer Survival by 925%

Here is the latest news from Theralse. We will be chatting with Roger shortly so if you have any questions please email or comment below….

Fri 28 Oct, 2016
12 comments

Health Canada Grants Theralase ITA Approval

Health Canada Grants Theralase ITA Approval Toronto, Ontario – October 20, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech company…

Thu 20 Oct, 2016
5 comments

Full interview with Roger White from Theralase

Here is the full interview with Theralase as featured on this week’s weekend show. If you have any follow up questions for Roger feel free…

Sat 8 Oct, 2016
4 comments

DID THIS DROP IN GOLD RESULT IN A BUYING OPPORTUNITY?

Segment 1: We recap the moves in the US markets, gold and the USD to kick off this week’s show. Segment 2: The True Contrarian,…

Sat 8 Oct, 2016
134 comments

Theralase Provides Update on ITA Application to Health Canada

Here is the latest news from Theralase. This release updated the status of the ITA filed with Health Canada for use of the Company’s “patent…

Wed 5 Oct, 2016
5 comments

Theralase Increases Revenue 32% in 2H2016 Financials

The news out today from Theralase focuses on the Q2 2016 financials. You can read the summariezex results below. We will also be having Roger…

Tue 30 Aug, 2016
13 comments

2016 Sprott Natural Resource Symposium

  Segment 1: Brent Cook, Founder of Exploration Insights, outlines a couple companies he likes at the Sprott Natural Resource Symposium. Segment 2: Al and…

Sat 30 Jul, 2016
157 comments

Theralase Files ITA Application to Health Canada

Theralase has now filed its ITA with Health Canada. Last week we said we would have Roger on the show but had to push that…

Fri 29 Jul, 2016
1 comment

Clinical and Scientific Research Reports for Theralase

Al and I recently meet up with Roger when he was passing through Vancouver and had a great chat. In the conversation Roger pointed us…

Tue 19 Jul, 2016
7 comments

Theralase Increases Revenue 11% in Q12016 Financials

For more information on the Q1 financial results click here to listen to an interview with Roger that was posted on the weekend. Here is…

Mon 30 May, 2016
0 comment

Theralase Q1 financials and an update on the ITA

Roger White took time to update us on the progress of the upcoming ITA as well as the recently released financials. We discuss the sales…

Sat 28 May, 2016
1 comment

Gold investment demand in the US is holding prices steady

Segment 1: Fund manager Dana Lyons provides his perspective on the potential of the US markets reaching all time highs. Segment 2: Chuck Provini, CEO…

Sat 14 May, 2016
285 comments

Theralase Signs Clinical Research Agreement with University Health Network

Here is the latest news from Theralase. We will be having Roger White on the weekend show so tune in to find out what is…

Thu 12 May, 2016
0 comment

Theralase Extends Research Agreement with University Health Network

Here is the latest news from Theralase. Reading through through the news real meat and bones is the following. “Theralase and UHN will work together…

Thu 28 Apr, 2016
2 comments

Chris Temple – Special Report on Theralase

Our friend Chris Temple from The National Investor just released a special report on Theralase. Below is a brief summary and a link to download…

Mon 25 Apr, 2016
1 comment

Update on Theralase TLC-2000 workforce and cancer division

Theralase (TLT:TSX.V) released news this morning so we brought CEO and President Roger White on the show for an update. We first get an update…

Fri 22 Apr, 2016
10 comments

Theralase Research Published in International Peer-Reviewed Journal

Please let us know if you have any questions or comments for Roger White over at Theralase. Here is the Company’s most recent news. Toronto,…

Fri 15 Apr, 2016
0 comment

An update from Roger White at Theralase

For those that are following the Theralase story you know that the Company has two divisions – a therapeutic laser division and a cancer division….

Thu 7 Apr, 2016
8 comments

Theralase Provides Update on 2016 Strategic Initiatives

If you have any questions for Roger regarding Theralase please leave them in the comment section or email Cory directly at fleck@kereport.com. I am expecting…

Fri 18 Mar, 2016
0 comment